Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?

被引：70
|
作者：
Fauser, BCJM
Devroey, P
机构：
[1] Univ Utrecht, Ctr Med, Dept Reprod Med, NL-3508 GA Utrecht, Netherlands
[2] Dutch Speaking Free Univ Brussels, Ctr Reprod Med, Brussels, Belgium
来源：
FERTILITY AND STERILITY | 2005年 / 83卷 / 06期
关键词：
D O I：
10.1016/j.fertnstert.2005.02.011
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The use of GnRH antagonist rather than agonist cotreatment during ovarian hyperstimulation for IVF is not widely accepted. Possible benefits, current shortcomings, and avenues for future development are discussed. (c) 2005 by American Society for Reproductive Medicine.
引用
收藏
页码：1607 / 1611
页数：5
相关论文
共 50 条
  • [1] Effect of Length of Controlled Ovarian Hyperstimulation Using a Gonadotropin-Releasing Hormone Antagonist on in Vitro Fertilization Pregnancy Rates
    Royster, G. Donald
    Retzloff, Matthew G.
    Robinson, Randal D.
    King, Jeremy A.
    Propst, Anthony M.
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (9-10) : 415 - 420
  • [2] Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
    Papanikolaou, EG
    Pozzobon, C
    Kolibianakis, EM
    Camus, M
    Tournaye, H
    Fatemi, HM
    Van Steirteghem, A
    Devroey, P
    [J]. FERTILITY AND STERILITY, 2006, 85 (01) : 112 - 120
  • [3] Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?
    Delvigne, A
    Carlier, C
    Rozenberg, S
    [J]. FERTILITY AND STERILITY, 2001, 76 (04) : 844 - 846
  • [4] Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist
    Williams, SC
    Gibbons, WE
    Muasher, SJ
    Oehninger, S
    [J]. FERTILITY AND STERILITY, 2002, 78 (05) : 1068 - 1072
  • [5] OVARIAN HYPERSTIMULATION FOR IN VITRO FERTILIZATION PRECEDED BY PROLONGED ADMINISTRATION OF A GONADOTROPIN-RELEASING HORMONE AGONIST
    Tanbo, Tom
    Dale, Per Olav
    Abyholm, Thomas
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1990, 69 (04) : 333 - 337
  • [6] Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation
    Seng, Shay Way
    Ong, Kee Jiet
    Ledger, W. L.
    [J]. WOMENS HEALTH, 2006, 2 (06) : 881 - 888
  • [7] Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation
    Albano, C
    Smitz, J
    Camus, M
    RiethmullerWinzen, H
    VanSteirteghem, A
    Devroey, P
    [J]. FERTILITY AND STERILITY, 1997, 67 (05) : 917 - 922
  • [8] Gonadotropin-Releasing Hormone Analog Cotreatment for Preservation of Ovarian Function
    Blumenfeld, Zeev
    [J]. ONCOLOGIST, 2012, 17 (02): : 162 - 163
  • [9] Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone
    Moon, SY
    Ku, SY
    Kim, SM
    Jee, BC
    Suh, CS
    Choi, YM
    Kim, JG
    Kim, SH
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2005, 31 (03) : 227 - 235
  • [10] Ovarian hyperstimulation with sole application of a gonadotropin-releasing hormone agonist
    Spitzer, D.
    Corn, C.
    Wirleitner, B.
    Zech, N. H.
    [J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2012, 10 (03): : 195 - 196
12345